Targeting tumor endothelial hyperglycolysis enhances immunotherapy through remodeling tumor microenvironment

Vascular abnormality is a hallmark of most solid tumors and facilitates immune evasion. Targeting the abnormal metabolism of tumor endothelial cells (TECs) may provide an opportunity to improve the outcome of immunotherapy. Here, in comparison to vascular endothelial cells from adjacent peritumoral...

Descripción completa

Detalles Bibliográficos
Autores principales: Shan, Yunlong, Ni, Qi, Zhang, Qixiang, Zhang, Mengying, Wei, Bin, Cheng, Lingge, Zhong, Chongjin, Wang, Xinyu, Wang, Qingqing, Liu, Jiali, Zhang, Jingwei, Wu, Jingjing, Wang, Guangji, Zhou, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279856/
https://www.ncbi.nlm.nih.gov/pubmed/35847509
http://dx.doi.org/10.1016/j.apsb.2022.02.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279856/
https://www.ncbi.nlm.nih.gov/pubmed/35847509
http://dx.doi.org/10.1016/j.apsb.2022.02.014

Ejemplares similares